Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR1 |
Variant | C379R |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | FGFR1 C379R (corresponds to C381R in the canonical isoform) lies within the transmembrane domain of the Fgfr1 protein (PMID: 26272615). C379R results in a gain of function, as demonstrated by constitutive Fgfr1 activity in a luciferase assay and increased Erk1/2 phosphorylation in cell culture (PMID: 26272615). |
Associated Drug Resistance | |
Category Variants Paths |
FGFR1 mutant FGFR1 act mut FGFR1 C379R |
Transcript | NM_015850.4 |
gDNA | chr8:g.38419676A>G |
cDNA | c.1135T>C |
Protein | p.C379R |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017013224.2 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_001354367.1 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_047421569.1 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_017013225 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_001410922.1 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_006716306 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_017013225.3 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_017013224 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_001354369.2 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_001174065.2 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_006716307.2 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_015850.4 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_017013225.2 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_006716307 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_001174065 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_015850 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_001174065.1 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_017013223 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
XM_006716307.1 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_001354367.2 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_015850.3 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
NM_001354369.1 | chr8:g.38419676A>G | c.1135T>C | p.C379R | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|